Anadys Pharmaceuticals (ANDS) Posts Wider than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts ANDS Hot Sheet
Price: $3.70 --0%
Financial Fact:
Interest income and other, net: 26K
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Interest income and other, net: 26K
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) reported Q3 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Carnival Corp. (CCL) Tops Q3 EPS by 8c
- Bassett Furniture Industries (BSET) Tops Q3 EPS by 11c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
